Radiation Therapy Planning Artificial Intelligence (AI) Market Report 2026

Radiation Therapy Planning Artificial Intelligence (AI) Market Overview

• Radiation Therapy Planning Artificial Intelligence (AI) market size has reached to $1.45 billion in 2025 • Expected to grow to $4.18 billion in 2030 at a compound annual growth rate (CAGR) of 23.6% • Growth Driver: Rising Focus On Personalized And Precision Radiation Therapy Fueling The Market Growth Due To Rising Adoption Of AI-Driven Treatment Planning • Market Trend: AI-Driven Automation Enhances Precision And Planning Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radiation Therapy Planning Artificial Intelligence (AI) Market?

radiation therapy planning artificial intelligence (AI) refers to artificial intelligence–powered software that assists in creating optimized, precise, and personalized radiation treatment plans for cancer patients. It automates tasks such as contouring, dose calculation, and treatment optimization to improve accuracy and efficiency. These systems enhance clinical outcomes by reducing planning time and minimizing human error. The main components of radiation therapy planning artificial intelligence solutions are software, hardware, and services. Software consists of artificial intelligence–driven planning platforms that automate contouring, dose calculation, and treatment plan optimization to improve precision and efficiency in radiation therapy workflows. These solutions are based on technologies such as machine learning, deep learning, and knowledge-based planning, deployed through on-premises and cloud-based models, used in applications including breast cancer, lung cancer, prostate cancer, head and neck cancer, and others, among end users such as hospitals, cancer treatment centers, research institutes, and others.

What Is The Radiation Therapy Planning Artificial Intelligence (AI) Market Growth Forecast?

The radiation therapy planning artificial intelligence (AI) market size is expected to see exponential growth in the next few years. It will grow to $4.18 billion in 2030 at a compound annual growth rate (CAGR) of 23.6%. The growth in the forecast period can be attributed to growing integration of cloud-based ai platforms, increasing investment in healthcare digitalization, rising demand for multi-cancer ai planning tools, expansion of research and development in oncology ai and increasing adoption in emerging markets. Major trends in the forecast period include technological advancements in ai-driven contouring and dose calculation, innovations in cloud-based radiation therapy platforms, development of predictive modeling for treatment outcomes, research and development in adaptive radiotherapy and technological advancements in workflow automation and quality assurance.

Global Radiation Therapy Planning Artificial Intelligence (AI) Market Segmentation

1) By Component: Software, Hardware, Services 2) By Technology: Machine Learning (ML), Deep Learning (DL), Knowledge-Based Planning (KBP) 3) By Deployment Mode: On-Premises, Cloud-Based 4) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Head And Neck Cancer, Other Applications 5) By End-User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users Subsegments: 1) By Software: Automated Contouring Software, Dose Prediction Software, Plan Optimization Software, Quality Assurance Software, Outcome Analytics Software 2) By Hardware: Graphics Processing Unit Servers, High Performance Computing Clusters, Dedicated Workstation Hardware, Edge Computing Devices 3) By Services: Implementation And Integration Services, Training And Support Services, Data Management Services, Clinical Validation Services

What Is The Driver Of The Radiation Therapy Planning Artificial Intelligence (AI) Market?

The rising focus on personalized and precision radiation therapy is expected to propel the growth of the radiation therapy planning artificial intelligence (AI) market going forward. Personalized and precision radiation therapy refers to tailoring radiation dose, delivery technique, and treatment planning specifically to the individual patient’s tumor characteristics and anatomy. Focus on personalized and precision radiation therapy is rising as clinicians seek to maximize tumor control while minimizing damage to surrounding healthy tissue by tailoring dose, targeting, and timing to each patient’s specific tumor biology and anatomy. The radiation therapy planning AI supports personalized and precision radiation therapy by offering automated tools that generate optimized, patient-specific treatment plans faster and with greater consistency than traditional manual methods. For instance, in May 2024, according to the Department for Health and Social Care, a UK government department, all National Health Service radiotherapy departments in England were allocated artificial intelligence technology through £15.5 million in government funding, with the technology automatically reviewing scans to distinguish between cancerous cells and healthy organs 2.5 times faster than previous methods, demonstrating growing adoption of precision radiotherapy techniques. Therefore, the rising focus on personalized and precision radiation therapy is driving the growth of the radiation therapy planning artificial intelligence (AI) industry.

Key Players In The Global Radiation Therapy Planning Artificial Intelligence (AI) Market

Major companies operating in the radiation therapy planning artificial intelligence (AI) market are Philips Healthcare, Siemens Healthineers AG, Elekta AB, Brainlab SE, Accuray Incorporated, RaySearch Laboratories AB, GE HealthCare, MVision AI, Spectra Medical India Pvt. Ltd., Coexya, LAP GmbH Laser Applikationen, Radformation Inc., TheraPanacea, DOSIsoft SA, Siris Medical Inc., Prowess Inc., Manteia Medical Technologies, Oncora Medical Inc., Adaptiiv Medical Technologies Inc., ViewRay Systems Inc., Pvmed Inc., Doctors App, Mirada Medical Ltd., Vision RT Ltd.

Global Radiation Therapy Planning Artificial Intelligence (AI) Market Trends and Insights

Major companies operating in the radiation therapy planning artificial intelligence (AI) market are focusing on developing advanced solutions, such as AI-driven automation and integrated tools, to boost precision, enhance clinical efficiency, and reduce manual planning time. AI-driven automation and integrated tools refer to sophisticated algorithms that streamline complex treatment planning processes, minimizing user intervention and variability. For instance, in July 2024, RaySearch Laboratories AB, a Sweden-based medical technology company, launched the RayStation 2024B treatment planning system. It is a comprehensive platform featuring advanced AI-based auto-contouring and a new Proton Monte Carlo dose calculation engine for unparalleled accuracy. It includes automated tools for adaptive therapy and plan optimization, enabling seamless integration of MR-Linac workflows and streamlined proton beam therapy planning without extensive manual effort. It also incorporates enhanced scripting and module integration, extending system versatility and reducing operational complexity for oncology clinics and research institutions.

What Are Latest Mergers And Acquisitions In The Radiation Therapy Planning Artificial Intelligence (AI) Market?

In May 2024, Radformation Inc., a US-based provider of automation software and clinical workflow tools for cancer care, acquired Limbus AI for an undisclosed amount. With this acquisition, Radformation aims to expand its AI-driven radiation therapy capabilities by integrating advanced automatic contouring technology into its planning and automation portfolio, enhancing clinical efficiency and treatment plan accuracy. Limbus AI is a Canada-based provider of machine learning-powered automatic contouring software used to improve workflows and efficiency in radiation therapy planning.

Regional Insights

North America was the largest region in the radiation therapy planning artificial intelligence (AI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiation Therapy Planning Artificial Intelligence (AI) Market?

The radiation therapy planning artificial intelligence (AI) market consists of revenues earned by entities by providing services such as AI-based treatment plan generation, dose optimization, image segmentation, tumor contouring, adaptive radiotherapy guidance, workflow automation, and clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation therapy planning artificial intelligence (AI) market includes sales of AI-based treatment planning software, image segmentation and contouring tools, dose calculation and optimization platforms, adaptive radiotherapy solutions, and integrated AI-enabled oncology workflow systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiation Therapy Planning Artificial Intelligence (AI) Market Report 2026?

The radiation therapy planning artificial intelligence (ai) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiation therapy planning artificial intelligence (ai) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.